Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-05T04:31:46.575Z Has data issue: false hasContentIssue false

Beneficial influence of an indigenous low-iron diet on serum indicators of iron status in patients with chronic liver disease

Published online by Cambridge University Press:  09 March 2007

Neelu Tandon
Affiliation:
Department of Gastroenterology, G.B. Pant Hospital, New Delhi, India
Varsha Thakur
Affiliation:
Department of Gastroenterology, G.B. Pant Hospital, New Delhi, India
Raj Kumar C. Guptan
Affiliation:
Department of Gastroenterology, G.B. Pant Hospital, New Delhi, India
Shiv K. Sarin*
Affiliation:
Department of Gastroenterology, G.B. Pant Hospital, New Delhi, India
*
*Corresponding author: Dr Shiv K. Sarin, fax +91 11 646 8691, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The main Fe storage organ in the body is the liver. In patients with chronic liver disease, secondary Fe overload is common. Phlebotomy, often used in the West to reduce Fe overload to improve the efficacy of interferon therapy, is not socially acceptable in India. We assessed the efficacy of a low-Fe diet in reducing serum Fe levels. Nineteen patients with hepatitis B- and C-related chronic liver disease, ten with normal (< 25 μmol/l) baseline serum Fe levels (group A) and nine with high (> 25 μmol/l) serum Fe levels (group B) were included. All the subjects were advised to eat a low-Fe diet. The daily Fe intake was reduced approximately 50 % by consumption of the rice-based diet. Haemoglobin, serum Fe, transferrin saturation index (TSI), ferritin and alanine transaminase (EC 2.6.1.2) levels were studied at 1 and 4 months. Dietary Fe intake and body weight were closely monitored. All patients complied with the dietary regimen and at 4 months significant (P < 0·001) reductions from baseline were seen in serum Fe (20 (SD 3) V. 12 (sd 4) μmol/l group A; 30 (sd 3) v. 19 (sd 7) μmol/l group B) and TSI (38 (sd 8) v. 23 (sd 9) % group A; 53 (sd 15) v. 34 (sd 13) %, group B) in both the groups, albeit earlier in group B subjects. Serum ferritin levels, however, reduced only in group A (112 (sd 62) v. 43 (sd 25) ng/ml, P < 0·05) and not in group B. Non-significant reductions in haemoglobin levels were seen in both groups. Alanine transaminase levels reduced significantly (P < 0·05) in both the groups (95 (sd 49) v. 44 (sd 25) IU/l, group A; 82 (sd 16) v. 51 (sd 14) IU/l group B). Thus, a low-Fe diet results in significant reductions in serum Fe and TSI levels, irrespective of baseline Fe levels. This diet should be evaluated to improve the efficacy of interferon therapy in patients with hepatitis B- and C-related chronic liver disease.

Type
Research Article
Copyright
Copyright © The Nutrition Society 2000

References

Aisen, P, Cohen, G and Kang Jo (1990) Iron toxicosis. International Reviews in Experimental Pathology 31, 146.CrossRefGoogle ScholarPubMed
Bacon, BR & Britton, RS (1997) Hereditary hemochromatosis. In Sleisenger and Fordtran's Gastrointestinal and Liver Disease, pp. 10971103 [Feldman, M, Scharschmidt, BF and Sleisenger, MH, editors]. Philadelphia, PA: W.B. Saunders Co.Google Scholar
Caraceni, P, Fagiuoli, S and Van Thiel, DH (1994) Iron reduction therapy: simply camouflage, or a real weapon? (Editorial). American Journal of Gastroenterology 89, 970973.Google ScholarPubMed
Child, CG & Turcotte, JG (1969) Surgery of portal hypertension. In The Liver and Portal Hypertension, p. 50 [Child, CG III, editor]. Philadelphia, PA: W.B. Saunders Co.Google Scholar
Food and Agriculture Organization/World Health Organization (1988) FAO/WHO Joint Expert Consultation Report. Requirement of Vitamin A, Iron, Folate and Vitamin B 12. Food and Nutrition Series no. 23. Rome: FAO.Google Scholar
Gopalan, CRama Sastri, BV & Balasubramanian, SC (1989) Nutritive Value of Indian Foods. Hyderabad: National Institute of Nutrition, Indian Council of Medical Research.Google Scholar
Guptan, RC, Malhotra, S, Khandekar, P and Sarin, SK (1994) Influence of low iron diet on the efficacy of interferon therapy in patients with chronic liver disease. Indian Journal of Gastroenterology 13, W9.Google Scholar
Hallberg, L (1981) Bioavailability of dietary iron in man. Annual Reviews in Nutrition 1, 123147.Google Scholar
Hallberg, L, Hulten, L, Bengtsson, C, Lapidus, L and Lindstedt, G (1995) Iron balance in menstruating women. European Journal of Clinical Nutrition 49, 200207.Google ScholarPubMed
Halliday, JW & Powell, LW (1992) Hemochromatosis and other diseases associated with iron overload. In Iron and Human Disease, pp. 132160 [Lauffer, RB, editor]. Boca Raton, FL: CRC Press.Google Scholar
Hayashi, H, Takikawa, T, Nishimura, N, Yano, M, Isomura, T and Sakamoto, N (1994) Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. American Journal of Gastroenterology 89, 986988.Google Scholar
Lynch, SR, Skikne, BS and Cook, JD (1989) Food iron absorption in idiopathic hemochromatosis. Blood 74, 21872193.CrossRefGoogle ScholarPubMed
Miller, GF, Barnard, DE, Woodward, RA, Flynn, BM and Bulte, JW (1997) Hepatic hemosiderosis in common marmosets, Callithrix jacchus: effect of diet on incidence and severity. Laboratory Animal Sciences 47, 138142.Google ScholarPubMed
Ryan, TP and Aust, SD (1992) The role of iron in oxygen mediated toxicities. Critical Reviews in Toxicology 22, 119141.CrossRefGoogle ScholarPubMed
Senba, M, Nakamura, T and Itakura, H (1985) Statistical analysis of relationship between iron accumulation and hepatitis B surface antigen. American Journal of Clinical Pathology 84, 340342.CrossRefGoogle Scholar
Taylor, P, Martinez-Torres C, Leets, I, Ramirez, J, Garciacasal, MN and Layrisse, M (1988) Relationships among iron absorption, percent saturation of plasma transferrin and serum ferritin concentrations in humans. Journal of Nutrition 118, 11101115.Google Scholar